G-CSF induces membrane expression of a myeloperoxidase glycovariant that operates as an E-selectin ligand on human myeloid cells

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 29, 2014, Pages 10696-10701

  Silvescu, Cristina I ^a,b   Sackstein, Robert ^a,b,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Glycosylation; Hematopoietic stem cell transplantation; Leukemia

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GLYCOPROTEIN; GRANULOCYTE COLONY STIMULATING FACTOR; MYELOPEROXIDASE; MYELOPEROXIDASE E SELECTIN LIGAND; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL SURFACE DISPLAY; CHEMICAL ANALYSIS; CONTROLLED STUDY; CYTOKINE RELEASE; ENDOTHELIUM CELL; ENZYME ACTIVE SITE; FUCOSYLATION; HEAVY CHAIN; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKOCYTE MIGRATION; LEUKOCYTE MOTILITY; LEUKOCYTOSIS; MASS SPECTROMETRY; MOUSE; MYELOPOIESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIALYLATION; VASCULAR ENDOTHELIUM;

GLYCOSYLATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; LEUKEMIA;

ANIMALS; BIOCATALYSIS; CELL MEMBRANE; E-SELECTIN; FUCOSE; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; LIGANDS; MICE; MOLECULAR WEIGHT; MUTATION; MYELOID CELLS; N-ACETYLNEURAMINIC ACID; PEROXIDASE; POLYSACCHARIDES; PROTEIN BINDING; UP-REGULATION;

EID: 84904698399     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1320833111     Document Type: Article

References (46)

1. Berliner N, et al. (1995) Granulocyte colony-stimulating factor induction of normal human bone marrow progenitors results in neutrophil-specific gene expression. Blood 85(3):799-803.
2. Panopoulos AD, Watowich SS (2008) Granulocyte colony-stimulating factor: Molecular mechanisms of action during steady state and 'emergency' hematopoiesis. Cytokine 42(3):277-288.
3. Elfenbein GJ, Sackstein R (2004) Primed marrow for autologous and allogeneic transplantation: A review comparing primed marrow to mobilized blood and steady-state marrow. Exp Hematol 32(4):327-339. (Pubitemid 38410908)
4. Sackstein R (2005) The lymphocyte homing receptors: Gatekeepers of the multistep paradigm. Curr Opin Hematol 12(6):444-450.
5. Fuhlbrigge RC, Kieffer JD, Armerding D, Kupper TS (1997) Cutaneous lymphocyte antigen is a specialized form of PSGL-1 expressed on skin-homing T cells. Nature 389(6654):978-981. (Pubitemid 27485690)
6. Sackstein R (2004) The bone marrow is akin to skin: HCELL and the biology of hematopoietic stem cell homing. J Invest Dermatol 122(5):1061-1069.
7. Hidalgo A, Peired AJ, Wild MK, Vestweber D, Frenette PS (2007) Complete identification of E-selectin ligands on neutrophils reveals distinct functions of PSGL-1, ESL-1, and CD44. Immunity 26(4):477-489. (Pubitemid 46603003)
8. Merzaban JS, et al. (2011) Analysis of glycoprotein E-selectin ligands on human and mouse marrow cells enriched for hematopoietic stem/progenitor cells. Blood 118(7):1774-1783.
9. Kotovuori P, et al. (1993) The vascular E-selectin binds to the leukocyte integrins CD11/CD18. Glycobiology 3(2):131-136. (Pubitemid 23132603)
10. Alcaide P, et al. (2007) The 130-kDa glycoform of CD43 functions as an E-selectin ligand for activated Th1 cells in vitro and in delayed-type hypersensitivity reactions in vivo. J Invest Dermatol 127(8):1964-1972. (Pubitemid 47075363)
11. Fuhlbrigge RC, King SL, Sackstein R, Kupper TS (2006) CD43 is a ligand for E-selectin on CLA+ human T cells. Blood 107(4):1421-1426. (Pubitemid 43242377)
12. Dagia NM, et al. (2006) G-CSF induces E-selectin ligand expression on human myeloid cells. Nat Med 12(10):1185-1190. (Pubitemid 44527355)
13. Allen RC, Stevens PR, Price TH, Chatta GS, Dale DC (1997) In vivo effects of recombinant human granulocyte colony-stimulating factor on neutrophil oxidative functions in normal human volunteers. J Infect Dis 175(5):1184-1192. (Pubitemid 27176508)
14. Sato N, Kashima K, Tanaka Y, Shimizu H, Mori M (1997) Effect of granulocyte-colony stimulating factor on generation of oxygen-derived free radicals and myeloperoxidase activity in neutrophils from poorly controlled NIDDM patients. Diabetes 46(1):133-137. (Pubitemid 27009961)
15. Strömberg K, Persson AM, Olsson I (1986) The processing and intracellular transport of myeloperoxidase. Modulation by lysosomotropic agents and monensin. Eur J Cell Biol 39(2):424-431.
16. Koeffler HP, Ranyard J, Pertcheck M (1985) Myeloperoxidase: Its structure and expression during myeloid differentiation. Blood 65(2):484-491. (Pubitemid 15163590)
17. Faulkner LB, et al. (1998) G-CSF serum pharmacokinetics during peripheral blood progenitor cell mobilization: Neutrophil count-adjusted dosage might potentially improve mobilization and be more cost-effective. Bone Marrow Transplant 21(11):1091-1095. (Pubitemid 28256649)
18. Handa K, Stroud MR, Hakomori S (1997) Sialosyl-fucosyl Poly-LacNAc without the sialosyl-Lex epitope as the physiological myeloid cell ligand in E-selectin-dependent adhesion: Studies under static and dynamic flow conditions. Biochemistry 36(41):12412-12420. (Pubitemid 27446663)
19. Nimrichter L, et al. (2008) E-selectin receptors on human leukocytes. Blood 112(9):3744-3752.
20. Zhang C, et al. (2001) Endothelial dysfunction is induced by proinflammatory oxidant hypochlorous acid. Am J Physiol Heart Circ Physiol 281(4):H1469-H1475.
21. Kettle AJ, Gedye CA, Winterbourn CC (1997) Mechanism of inactivation of myeloperoxidase by 4-aminobenzoic acid hydrazide. Biochem J 321(Pt 2):503-508. (Pubitemid 27056501)
22. Hansson M, Olsson I, Nauseef WM (2006) Biosynthesis, processing, and sorting of human myeloperoxidase. Arch Biochem Biophys 445(2):214-224. (Pubitemid 43082214)
23. Eiserich JP, et al. (2002) Myeloperoxidase, a leukocyte-derived vascular NO oxidase. Science 296(5577):2391-2394. (Pubitemid 34734213)
24. Eiserich JP, et al. (1998) Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature 391(6665):393-397. (Pubitemid 28093514)
25. Lau D, Baldus S (2006) Myeloperoxidase and its contributory role in inflammatory vascular disease. Pharmacol Ther 111(1):16-26. (Pubitemid 43765542)
26. De Caterina R, et al. (1995) Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 96(1):60-68.
27. Kubes P, Suzuki M, Granger DN (1991) Nitric oxide: An endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 88(11):4651-4655. (Pubitemid 21914599)
28. Saleh AW, Hillen HF, Duits AJ (1999) Levels of endothelial, neutrophil and platelet-specific factors in sickle cell anemia patients during hydroxyurea therapy. Acta Haematol 102(1):31-37. (Pubitemid 29417701)
29. Baldus S, et al.; CAPTURE Investigators (2003) Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation 108(12):1440-1445. (Pubitemid 37176448)
30. Zhang R, et al. (2001) Association between myeloperoxidase levels and risk of coronary artery disease. JAMA 286(17):2136-2142. (Pubitemid 34041599)
31. Hazell LJ, et al. (1996) Presence of hypochlorite-modified proteins in human atherosclerotic lesions. J Clin Invest 97(6):1535-1544. (Pubitemid 26097044)
32. Malle E, et al. (2000) Immunohistochemical evidence for the myeloperoxidase/H2O2/halide system in human atherosclerotic lesions: Colocalization of myeloperoxidase and hypochlorite-modified proteins. Eur J Biochem 267(14):4495-4503. (Pubitemid 30461082)
33. Breckwoldt MO, et al. (2008) Tracking the inflammatory response in stroke in vivo by sensing the enzyme myeloperoxidase. Proc Natl Acad Sci USA 105(47):18584-18589.
34. Fukumoto Y, et al. (1997) Angina pectoris occurring during granulocyte colony-stimulating factor-combined preparatory regimen for autologous peripheral blood stem cell transplantation in a patient with acute myelogenous leukaemia. Br J Haematol 97(3):666-668. (Pubitemid 27261638)
35. Hill JM, et al. (2005) Outcomes and risks of granulocyte colony-stimulating factor in patients with coronary artery disease. J Am Coll Cardiol 46(9):1643-1648. (Pubitemid 41531616)
36. Fitzhugh CD, Hsieh MM, Bolan CD, Saenz C, Tisdale JF (2009) Granulocyte colony-stimulating factor (G-CSF) administration in individuals with sickle cell disease: Time for a moratorium? Cytotherapy 11(4):464-471.
37. Chang J, et al. (2010) GMI-1070, a novel pan-selectin antagonist, reverses acute vascular occlusions in sickle cell mice. Blood 116(10):1779-1786.
38. Noguchi N, et al. (2000) Role of myeloperoxidase in the neutrophil-induced oxidation of low density lipoprotein as studied by myeloperoxidase-knockout mouse. J Biochem 127(6):971-976. (Pubitemid 30430150)
39. Sackstein R (2012) Engineering cellular trafficking via glycosyltransferase-programmed stereosubstitution. Ann N Y Acad Sci 1253(1):193-200.
40. Ieremia J, Blau CA (2002) Limitations of a mouse model of sickle cell anemia. Blood Cells Mol Dis 28(2):146-151. (Pubitemid 34743748)
41. Iking-Konert C, et al. (2004) Granulocyte colony-stimulating factor induces disease flare in patients with antineutrophil cytoplasmic antibody-associated vasculitis. J Rheumatol 31(8):1655-1658. (Pubitemid 39006651)
42. Vasiliu IM, Petri MA, Baer AN (2006) Therapy with granulocyte colony-stimulating factor in systemic lupus erythematosus may be associated with severe flares. J Rheumatol 33(9):1878-1880. (Pubitemid 44373227)
43. Glass LF, Fotopoulos T, Messina JL (1996) A generalized cutaneous reaction induced by granulocyte colony-stimulating factor. J Am Acad Dermatol 34(3):455- 459.
44. Falk RJ, Jennette JC (1988) Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med 318(25):1651-1657.
45. Tervaert JW, et al. (1991) Detection of autoantibodies against myeloid lysosomal enzymes: A useful adjunct to classification of patients with biopsy-proven necrotizing arteritis. Am J Med 91(1):59-66.
46. Bansal PJ, Tobin MC (2004) Neonatal microscopic polyangiitis secondary to transfer of maternal myeloperoxidase-antineutrophil cytoplasmic antibody resulting in neonatal pulmonary hemorrhage and renal involvement. Ann Allergy Asthma Immunol 93(4):398-401. (Pubitemid 39382982)